Literature DB >> 15611229

Distinct calcium channels regulate responses of primary B lymphocytes to B cell receptor engagement and mechanical stimuli.

Qing-Hua Liu1, Xiaohong Liu, Zhiyun Wen, Brian Hondowicz, Leslie King, John Monroe, Bruce D Freedman.   

Abstract

Intracellular Ca(2+) plays a central role in controlling lymphocyte function. Nonetheless, critical gaps remain in our understanding of the mechanisms that regulate its concentration. Although Ca(2+)-release-activated calcium (CRAC) channels are the primary Ca(2+) entry pathways in T cells, additional pathways appear to be operative in B cells. Our efforts to delineate these pathways in primary murine B cells reveal that Ca(2+)-permeant nonselective cation channels (NSCCs) operate in a cooperative fashion with CRAC. Interestingly, these non-CRAC channels are selectively activated by mechanical stress, although the mechanism overlaps with BCR-activated pathways, suggesting that they may operate in concert to produce functionally diverse Ca(2+) signals. NSCCs also regulate the membrane potential, which activates integrin-dependent binding of B cells to extracellular matrix elements involved in their trafficking and localization within secondary lymphoid organs. Thus, CRAC and distinct Ca(2+) permeant NSCCs are differentially activated by the BCR and mechanical stimuli and regulate distinct aspects of B cell physiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15611229     DOI: 10.4049/jimmunol.174.1.68

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Ca2+ influx and protein scaffolding via TRPC3 sustain PKCbeta and ERK activation in B cells.

Authors:  Takuro Numaga; Motohiro Nishida; Shigeki Kiyonaka; Kenta Kato; Masahiro Katano; Emiko Mori; Tomohiro Kurosaki; Ryuji Inoue; Masaki Hikida; James W Putney; Yasuo Mori
Journal:  J Cell Sci       Date:  2010-02-23       Impact factor: 5.285

Review 2.  Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

Authors:  Jogen Atone; Karen Wagner; Kenji Hashimoto; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-11-05       Impact factor: 3.072

Review 3.  Ion channels in innate and adaptive immunity.

Authors:  Stefan Feske; Heike Wulff; Edward Y Skolnik
Journal:  Annu Rev Immunol       Date:  2015       Impact factor: 28.527

Review 4.  Calcium signalling and cell-fate choice in B cells.

Authors:  Andrew M Scharenberg; Lisa A Humphries; David J Rawlings
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

Review 5.  B-lymphocyte calcium influx.

Authors:  Leslie B King; Bruce D Freedman
Journal:  Immunol Rev       Date:  2009-09       Impact factor: 12.988

6.  Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells.

Authors:  Peimin Zhu; Xiaohong Liu; Laura S Treml; Michael P Cancro; Bruce D Freedman
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

7.  Role of initial protein phosphorylation events and localized release-activated calcium influx in B cell antigen receptor signaling.

Authors:  Taras Lyubchenko; J Paul Nielsen; Sara M Miller; Ganna A Liubchenko; V Michael Holers
Journal:  J Leukoc Biol       Date:  2008-11-21       Impact factor: 4.962

8.  Mechanosensitive activation of K+ channel via phospholipase C-induced depletion of phosphatidylinositol 4,5-bisphosphate in B lymphocytes.

Authors:  Joo Hyun Nam; Hoo-Se Lee; Yen Hoang Nguyen; Tong Mook Kang; Sung Won Lee; Hye-Young Kim; Sang Jeong Kim; Yung E Earm; Sung Joon Kim
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

9.  Downregulation of Orai1 expression in the airway alleviates murine allergic rhinitis.

Authors:  Yi Wang; Lin Lin; Chunquan Zheng
Journal:  Exp Mol Med       Date:  2012-03-31       Impact factor: 8.718

Review 10.  ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyond.

Authors:  Stefan Feske
Journal:  Immunol Rev       Date:  2009-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.